Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin vs Metformin in PCOS with NAFLD
NCT06256289Phase 4Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of canagliflozin in polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD). Planned start Mar 2024; status: not yet recruiting.
02
Drugs
canagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06256289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256289.